Sentence examples for cancer expression analysis from inspiring English sources
The robust gene HIF1A might be ignored in the colorectal cancer expression analysis.
MDR gives highly competitive results, producing the highest average AUC, 91.01%, and an average overall accuracy of 90.01% for cancer expression analysis.
Peer-reviewed publications on ovarian cancer gene expression analysis were identified in PubMed [ 56], accessed in June 2005, applying a keyword search (ovarian cancer, gene expression, microarrays).
Another significant advance in the identification of prognostic factors using breast cancer microarray expression analysis was the 70-gene signature generated in axillary lymph node-negative patients by van't Veer et al. [3].
On the contrary, BAFF overexpression was not associated with prognosis or tumor aggressiveness using online cancer gene expression analysis[ 32].
Although it continues to serve as an invasion and MMP inhibitor in breast cancer, RECK expression analysis is not useful for prognosis of these patients.
"Oncomine" [ 6] was developed for cancer gene expression analysis; "The Tumour Gene Family of Databases" [ 7] contains information about genes which are targets for cancer-causing mutations; the "BreastCancerDatabase" [ 8] collects molecular alterations associated with breast cancer; the "Breast Cancer Information Core Database" [ 9] stores mutations of main breast cancer genes.
In a strategy aimed at identifying novel markers of human prostate cancer, we performed expression analysis using microarrays of clones randomly selected from a cDNA library prepared from the LNCaP prostate cancer cell line.
All patients underwent a one-time, pretreatment, fine-needle biopsy of the cancer for gene expression analysis.
Ductal carcinoma in situ (DCIS) can be classified into the same molecular subtypes as invasive breast cancer by gene expression analysis [ 5, 6].
The reduced KLK5 transcription in the malignant cells was also revealed by the breast cancer patients' KLK5 expression analysis in quartiles, compared to the same analysis of the control cohort of patients with benign breast modifications (Table 1).
